MBII - Marrone Bio Innovations, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue14,0429,8019,136
Cost of Revenue9,5229,2569,438
Gross Profit4,520545-302
Operating Expenses
Research Development9,67013,50019,281
Selling General and Administrative18,51026,50228,950
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-23,660-39,457-48,533
Income from Continuing Operations
Total Other Income/Expenses Net-10992-219
Earnings Before Interest and Taxes-23,769-39,365-48,752
Interest Expense7,3024,3632,907
Income Before Tax-31,071-43,728-51,659
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-31,071-43,728-51,659
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-31,071-43,728-51,659
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-31,071-43,728-51,659